* Mustang Bio Inc MBIO.OQ reported a quarterly adjusted loss
of 16 cents per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 20 cents per share.
* Reported revenue was zero; analysts expected zero.
* Mustang Bio Inc's reported EPS for the quarter was a loss
of 16 cents.
* The mean earnings estimate of analysts had risen by about 3.2%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Mustang Bio Inc shares had fallen by 17.8% this quarter and
lost 27.9% so far this year.
* The company reported a quarterly loss of $14.36 million.
* Wall Street's median 12-month price target for Mustang Bio Inc
is $11.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated August 16 at 09:27 p.m. All
figures in US dollars unless otherwise stated